The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Invasive candidiasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationEpigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
Saeed, S., Quintin, J., Kerstens, H. H. D., Rao, N. A., Aghajanirefah, A., Matarese, F., Cheng, S.-C., Ratter, J., Berentsen, K., van der Ent, M. A., et al. (2014) · Science · doi:10.1126/science.1251086 · Cited by 1,761 · cited 1×
“Monocytes and macrophages also confer lymphocyte-independent protection through epigenetic reprogramming, resulting in innate memory through a dectin 1-dependent pathway 79 .”
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationPappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Self-citationNosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Evolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“Some important exceptions include the common species N. glabratus , which is more closely related to Saccharomyces cerevisiae , and Pichia kudriavzevii (formerly Candida krusei) 37 .”
Blauwkamp, T. A., Thair, S., Rosen, M. J., Blair, L., Lindner, M. S., Vilfan, I. D., Kawli, T., Christians, F. C., Venkatasubrahmanyam, S., Wall, G. D., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0349-6 · Cited by 962 · cited 1×
“One example of a mNGS platform is the Karius test, which detects cell-free DNA (cfDNA) from plasma of over 1,250 human pathogens, including bacteria, fungi and DNA viruses 167 .”
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900 · cited 1×
“Large-scale epidemiological studies have shown a resistance rate to fluconazole of 0–5% 129 .”
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“This is highlighted by the fact that defects in TLR and complement pathways do not substantially increase susceptibility to infection as opposed to deficiency in caspase recruitment domain-containing protein 9 (CARD9), a key molecule in the CLR pathway 69 .”
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794 · cited 3×
“Each morphological form possesses distinct surface molecules 53 .”
InfluentialAndes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Benjamin, D. K., Stoll, B. J., Fanaroff, A. A., McDonald, S. A., Oh, W., Higgins, R. D., Duara, S., Poole, K., Laptook, A., Goldberg, R., et al. (2006) · Pediatrics · doi:10.1542/peds.2004-2292 · Cited by 667
León, C., Ruiz-Santana, S., Saavedra, P., Almirante, B., Nolla-Salas, J., Álvarez-Lerma, F., Garnacho-Montero, J., & León, M. Á. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202208.37364.7d · Cited by 659 · cited 2×
“Hence, the role of screening for Candida colonization as part of the evaluation of a Candida scoring system (bedside assessment integrating total parenteral nutrition, surgery, multifocal Candida colonization and severe sepsis 102 ) was investigated in several studies 114,115 .”
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642 · cited 1×
“for example, mutations in immune-related genes might predispose individuals to invasive Candida infections 35 .”
Candida auris: Epidemiology, biology, antifungal resistance, and virulence
Du, H., Bing, J., Hu, T., Ennis, C. L., Nobile, C. J., & Huang, G. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008921 · Cited by 609
Rex, J. H., Pappas, P. G., Karchmer, A. W., Sobel, J., Edwards, J. E., Hadley, S., Brass, C., Vazquez, J. A., Chapman, S. W., Horowitz, H. W., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374850 · Cited by 495
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2022) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 477
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · cited 1×
“…triazole therapy may have higher rates of fluconazole resistance with overexpression of genes encoding lanosterol 14α-demethylase ( ERG11 ) and efflux transporters ( MDR1 , CDR1 and CDR2 ) being the most frequently identified mechanisms; amino acid substitutions are less frequently observed 130 .”
Bloodstream infections in critically ill patients: an expert statement
Timsit, J.-F., Ruppé, E., Barbier, F., Tabah, A., & Bassetti, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05950-6 · Cited by 448
Revisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424
Trends in age‐related disease burden and healthcare utilization
Atella, V., Piano Mortari, A., Kopinska, J., Belotti, F., Lapi, F., Cricelli, C., & Fontana, L. (2019) · Aging Cell · doi:10.1111/acel.12861 · Cited by 405
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.
Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12038 · Cited by 386
Self-citationEpidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Self-citationHope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360
Self-citationMorbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336 · cited 3×
“The burden of disease is markedly higher in hospitalized patients worldwide (~100 per 100,000 admissions) 14–16 , with the highest incidence in patients in the ICU, reaching 5.5–7 episodes per 1,000 ICU admissions 12,17,18 .”
InfluentialUllmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334
Self-citationGarcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323
The rapid emergence of antifungal-resistant human-pathogenic fungi
Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 308
Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing
Wilson, M. R., O’Donovan, B. D., Gelfand, J. M., Sample, H. A., Chow, F. C., Betjemann, J. P., Shah, M. P., Richie, M. B., Gorman, M. P., Hajj-Ali, R. A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0463 · Cited by 303
Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis
Lionakis, M. S., Lim, J. K., Lee, C.-C. R., & Murphy, P. M. (2011) · Journal of Innate Immunity · doi:10.1159/000321157 · Cited by 302
Diagnosing invasive candidiasis
Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01909-17 · Cited by 293 · cited 1×
“Candidaemia is a low-prevalence disease and varies from 1% to 10% 117 .”
The regulation of hyphae growth in Candida albicans
Chen, H., Zhou, X., Ren, B., & Cheng, L. (2020) · Virulence · doi:10.1080/21505594.2020.1748930 · Cited by 277
Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276
Bassetti, M., Giacobbe, D. R., Vena, A., Trucchi, C., Ansaldi, F., Antonelli, M., Adamkova, V., Alicino, C., Almyroudi, M.-P., Atchade, E., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2497-3 · Cited by 270
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
Daneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00067-8 · Cited by 257
CARD9+ microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment
Drummond, R. A., Swamydas, M., Oikonomou, V., Zhai, B., Dambuza, I. M., Schaefer, B. C., Bohrer, A. C., Mayer-Barber, K. D., Lira, S. A., Iwakura, Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0377-2 · Cited by 238
Arendrup, M. C., Friberg, N., Mares, M., Kahlmeter, G., Meletiadis, J., Guinea, J., Arendrup, M. C., Meletiadis, J., Guinea, J., Friberg, N., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.007 · Cited by 238
Self-citationBenjamin, D. K., Poole, C., Steinbach, W. J., Rowen, J. L., & Walsh, T. J. (2003) · Pediatrics · doi:10.1542/peds.112.3.634 · Cited by 236
CX3CR1-dependent renal macrophage survival promotes Candida control and host survival
Lionakis, M. S., Swamydas, M., Fischer, B. G., Plantinga, T. S., Johnson, M. D., Jaeger, M., Green, N. M., Masedunskas, A., Weigert, R., Mikelis, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71307 · Cited by 230
Wiseman, A. C. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08570814 · Cited by 230
Candidalysin: discovery and function in Candida albicans infections
Naglik, J. R., Gaffen, S. L., & Hube, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.06.002 · Cited by 229
Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217 · cited 1×
“N. glabratus exhibits frequent resistance to azoles mediated by changes in drug efflux (Cdr1 and Cdr2) 132 .”
Update on Candida krusei , a potential multidrug-resistant pathogen
Jamiu, A. T., Albertyn, J., Sebolai, O. M., & Pohl, C. H. (2020) · Medical Mycology · doi:10.1093/mmy/myaa031 · Cited by 211
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis
Tissot, F., Lamoth, F., Hauser, P. M., Orasch, C., Flückiger, U., Siegemund, M., Zimmerli, S., Calandra, T., Bille, J., Eggimann, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2069oc · Cited by 203
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
Proctor, D. M., Dangana, T., Sexton, D. J., Fukuda, C., Yelin, R. D., Stanley, M., Bell, P. B., Baskaran, S., Deming, C., Chen, Q., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01383-w · Cited by 198
Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02324-8 · Cited by 192
Self-citationThe central nervous system and infection by Candida species
Sánchez–Portocarrero, J., Pérez–Cecilia, E., Corral, O., Romero–Vivas, J., & Picazo, J. J. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00140-1 · Cited by 191
Invasive candidiasis in critical care: challenges and future directions
Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06240-x · Cited by 180
Candida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177 · cited 1×
“This multidrug-resistant species is a health-care-associated organism with the potential of outbreaks 120 and may remain in the environment for weeks 121 .”
Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival
Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 165
Self-citationBurden of Candidemia in the United States, 2017
Tsay, S. V., Mu, Y., Williams, S., Epson, E., Nadle, J., Bamberg, W. M., Barter, D. M., Johnston, H. L., Farley, M. M., Harb, S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa193 · Cited by 163
Thompson, G. R., Wiederhold, N. P., Vallor, A. C., Villareal, N. C., Lewis, J. S., & Patterson, T. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00473-08 · Cited by 160
Self-citationManagement of central venous catheters in patients with cancer and candidemia
Raad, I., Hanna, H., Boktour, M., Girgawy, E., Danawi, H., Mardani, M., Kontoyiannis, D., Darouiche, R., Hachem, R., & Bodey, G. P. (2004) · Clinical Infectious Diseases · doi:10.1086/382874 · Cited by 159
Gazendam, R. P., van de Geer, A., Roos, D., van den Berg, T. K., & Kuijpers, T. W. (2016) · Immunological Reviews · doi:10.1111/imr.12454 · Cited by 159
The Candida albicans Biofilm Matrix: Composition, Structure and Function
Pierce, C., Vila, T., Romo, J., Montelongo-Jauregui, D., Wall, G., Ramasubramanian, A., & Lopez-Ribot, J. (2017) · Journal of Fungi · doi:10.3390/jof3010014 · Cited by 159
Adjuvant Corticosteroid Therapy for Chronic Disseminated Candidiasis
Legrand, F., Lecuit, M., Dupont, B., Bellaton, E., Huerre, M., Rohrlich, P.-S., & Lortholary, O. (2008) · Clinical Infectious Diseases · doi:10.1086/527390 · Cited by 157 · cited 2×
“This partly explains some studies demonstrating benefit in patients receiving steroids as adjuvant to antifungal therapy 88 .”
Hoenigl, M., Salmanton-García, J., Egger, M., Gangneux, J.-P., Bicanic, T., Arikan-Akdagli, S., Alastruey-Izquierdo, A., Klimko, N., Barac, A., Özenci, V., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00872-6 · Cited by 152
Self-citationThe changing epidemiology of fungal infections
Lass‐Flörl, C., & Steixner, S. J. M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101215 · Cited by 151
Self-citationIntra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
Vergidis, P., Clancy, C. J., Shields, R. K., Park, S. Y., Wildfeuer, B. N., Simmons, R. L., & Nguyen, M. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153247 · Cited by 150
Systemic antifungal therapy in critically ill patients without invasive fungal infection*
Azoulay, É., Dupont, H., Tabah, A., Lortholary, O., Stahl, J. ‐., Français, A., Martin, C., Guidet, B., & Timsit, J. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f297 · Cited by 148
Environmental Candida auris and the Global Warming Emergence Hypothesis
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2021) · mBio · doi:10.1128/mbio.00360-21 · Cited by 145
Mechanism of Candida pathogenesis: Revisiting the vital drivers
Mba, I. E., & Nweze, E. I. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03912-w · Cited by 143
Inflammatory Monocytes Mediate Early and Organ-Specific Innate Defense During Systemic Candidiasis
Ngo, L. Y., Kasahara, S., Kumasaka, D. K., Knoblaugh, S. E., Jhingran, A., & Hohl, T. M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit413 · Cited by 143
A Candida auris –specific adhesin, Scf1 , governs surface association, colonization, and virulence
Santana, D. J., Anku, J. A. E., Zhao, G., Zarnowski, R., Johnson, C. J., Hautau, H., Visser, N. D., Ibrahim, A. S., Andes, D., Nett, J. E., et al. (2023) · Science · doi:10.1126/science.adf8972 · Cited by 142
Host response toCandida albicansbloodstream infection and sepsis
Duggan, S., Leonhardt, I., Hünniger, K., & Kurzai, O. (2015) · Virulence · doi:10.4161/21505594.2014.988096 · Cited by 141
The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic
Seagle, E. E., Jackson, B. R., Lockhart, S. R., Georgacopoulos, O., Nunnally, N. S., Roland, J., Barter, D. M., Johnston, H. L., Czaja, C. A., Kayalioglu, H., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab562 · Cited by 141
Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–20171
van Schalkwyk, E., Mpembe, R. S., Thomas, J., Shuping, L., Ismail, H., Lowman, W., Karstaedt, A. S., Chibabhai, V., Wadula, J., Avenant, T., et al. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190040 · Cited by 137
Self-citationKidney Disease Among African Americans: A Population Perspective
Laster, M. L., Shen, J. I., & Norris, K. C. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.021 · Cited by 136
Antifungals: From Pharmacokinetics to Clinical Practice
do Carmo, A., Rocha, M. J., Pereirinha, P., Tomé, R., & Costa, E. (2023) · Antibiotics · doi:10.3390/antibiotics12050884 · Cited by 132
Mechanisms of fungal dissemination
Strickland, A. B., & Shi, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03736-z · Cited by 127
Invasive Fungal Infections in Patients with Chronic Granulomatous Disease
Henriet, S., Verweij, P. E., Holland, S. M., & Warris, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4726-9_3 · Cited by 125
Serology anno 2021—fungal infections: from invasive to chronic
Lass‐Flörl, C., Samardzic, E., & Knoll, M. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.02.005 · Cited by 123
Self-citationCandida albicans Hyphal Expansion Causes Phagosomal Membrane Damage and Luminal Alkalinization
Westman, J., Moran, G. P., Mogavero, S., Hube, B., & Grinstein, S. (2018) · mBio · doi:10.1128/mbio.01226-18 · Cited by 119
Warris, A., Pana, Z. D., Oletto, A., Lundin, R., Castagnola, E., Lehrnbecher, T., Groll, A. H., & Roilides, E. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002530 · Cited by 119
Lionakis, M. S., Fischer, B. G., Lim, J. K., Swamydas, M., Wan, W., Richard Lee, C.-C., Cohen, J. I., Scheinberg, P., Gao, J.-L., & Murphy, P. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002865 · Cited by 118 · cited 1×
“Multiple receptors (that is, CR3 and galectin 3) and cytokines are implicated as major drivers of excessive neutrophilic response 85,86 .”
New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis
Rammaert, B., Desjardins, A., & Lortholary, O. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02182.x · Cited by 118
Invasive candidiasis species distribution and trends, United States, 2009-2017
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa502 · Cited by 114 · cited 2×
“The burden of disease is markedly higher in hospitalized patients worldwide (~100 per 100,000 admissions) 14–16 , with the highest incidence in patients in the ICU, reaching 5.5–7 episodes per 1,000 ICU admissions 12,17,18 .”
InfluentialMellinghoff, S. C., Hoenigl, M., Koehler, P. A., Kumar, A., Lagrou, K., Lass‐Flörl, C., Meis, J. F. G. M., Menon, V. P., Rautemaa‐Richardson, R., & Cornely, O. A. (2018) · Mycoses · doi:10.1111/myc.12746 · Cited by 113
Self-citationEvolutionary instability of CUG-Leu in the genetic code of budding yeasts
Krassowski, T., Coughlan, A. Y., Shen, X., Zhou, X., Kominek, J., Opulente, D. A., Riley, R. W., Grigoriev, I. V., Maheshwari, N., Shields, D. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04374-7 · Cited by 106
Lyman, M., Forsberg, K., Reuben, J., Dang, T., Free, R., Seagle, E. E., Sexton, D. J., Soda, E., Jones, H., Hawkins, D., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7029a2 · Cited by 104
Candida albicans Interactions with Mucosal Surfaces during Health and Disease
Nikou, S.-A., Kichik, N., Brown, R., Ponde, N., Ho, J., Naglik, J., & Richardson, J. (2019) · Pathogens · doi:10.3390/pathogens8020053 · Cited by 103
Shastri, P. S., Shankarnarayan, S. A., Oberoi, J., Rudramurthy, S. M., Wattal, C., & Chakrabarti, A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.01.004 · Cited by 103
Strategies to Prevent Transmission of Candida auris in Healthcare Settings
Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 100
Utility of Ophthalmologic Screening for Patients With Candida Bloodstream Infections
Breazzano, M. P., Day, H. R., Bloch, K. C., Tanaka, S., Cherney, E. F., Sternberg, P. W., Donahue, S. P., & Bond, J. B. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.0733 · Cited by 98
Immune Sensing of Candida albicans
Bojang, E., Ghuman, H., Kumwenda, P., & Hall, R. A. (2021) · Journal of Fungi · doi:10.3390/jof7020119 · Cited by 96
Candida parapsilosis complex in the clinical setting
Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 94
Self-citationBreazzano, M. P., Bond, J. B., Bearelly, S., Kim, D. H., Donahue, S. P., Lum, F., & Olsen, T. W. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2021.07.015 · Cited by 91
Invasive fungal infections in neonates: a review
Weimer, K. E. D., Smith, P. B., Puia‐Dumitrescu, M., & Aleem, S. (2021) · Pediatric Research · doi:10.1038/s41390-021-01842-7 · Cited by 91
“ Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier”
Basmaciyan, L., Bon, F., Paradis, T., Lapaquette, P., & Dalle, F. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1612661 · Cited by 89
Grubb, S. E. W., Murdoch, C., Sudbery, P. E., Saville, S. P., Lopez-Ribot, J. L., & Thornhill, M. H. (2008) · Infection and Immunity · doi:10.1128/iai.00332-08 · Cited by 87
Rolling, T., Zhai, B., Gjonbalaj, M., Tosini, N. L., Yasuma-Mitobe, K., Fontana, E., Amoretti, L. A., Wright, R. J., Ponce, D. M., Perales, M., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00989-7 · Cited by 86
The emerging threat antifungal-resistant Candida tropicalis in humans, animals, and environment
Lima, R., Ribeiro, F. D. C., Colombo, A. L., & de Almeida, J. N. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.957021 · Cited by 85
Let’s talk about sex characteristics—as a risk factor for invasive fungal diseases.
Egger, M., Hoenigl, M., Thompson, G. R., Carvalho, A., & Jenks, J. D. (2022) · Mycoses · doi:10.1111/myc.13449 · Cited by 82
Self-citationDonders, G., Sziller, I. O., Paavonen, J., Hay, P., de Seta, F., Bohbot, J. M., Kotarski, J., Vives, J. A., Szabo, B., Cepuliené, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934353 · Cited by 82
Posteraro, B., Tumbarello, M., PASCALE, G. D., Liberto, E., Vallecoccia, M. S., Carolis, E. D., Gravio, V. D., Trecarichi, E. M., Sanguinetti, M., & Antonelli, M. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw112 · Cited by 82
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., et al. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy009 · Cited by 81 · cited 3×
“In addition, during the past few years, the population at risk expanded due to COVID-19-related C andida infections 164 and the emergence of fungal break-through infections 165 .”
Vázquez, N., Walsh, T. J., Friedman, D. R., Chanock, S. J., & Lyman, C. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.145-150.1998 · Cited by 80
Megri, Y., Arastehfar, A. A., Boekhout, T., Daneshnia, F., Hörtnagl, C., Sartori, B., Hafez, A. I., Pan, W., Lass‐Flörl, C., & Hamrioui, B. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00710-z · Cited by 80
Self-citationCandida auris as an Emergent Public Health Problem: A Current Update on European Outbreaks and Cases
Geremia, N., Brugnaro, P., Solinas, M. L., Scarparo, C., & Panese, S. (2023) · Healthcare · doi:10.3390/healthcare11030425 · Cited by 79
T2Candida for the Diagnosis and Management of Invasive Candida Infections
Monday, L., Acosta, T. J. P., & Alangaden, G. J. (2021) · Journal of Fungi · doi:10.3390/jof7030178 · Cited by 78
Mashau, R. C., Meiring, S. T., Dramowski, A., Magobo, R. E., Quan, V., Perovic, O., von Gottberg, A., Cohen, C., Velaphi, S., van Schalkwyk, E., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00246-7 · Cited by 77
Self-citationAnalysis of Candida auris fungemia at a single facility in Kenya
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.001 · Cited by 76
Phongkhun, K., Pothikamjorn, T. L., Srisurapanont, K., Manothummetha, K., Sanguankeo, A., Thongkam, A., Chuleerarux, N., Leksuwankun, S., Meejun, T., Thanakitcharu, J., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad064 · Cited by 75
Verweij, P. E., Arendrup, M. C., Alastruey‐Izquierdo, A., Gold, J. A. W., Lockhart, S. R., Chiller, T. M., & White, P. L. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100885 · Cited by 73
Kilburn, S., Innes, G. K., Quinn, M., Southwick, K. L., Ostrowsky, B. E., Greenko, J. A., Lutterloh, E. C., Greeley, R. D., Magleby, R., Chaturvedi, V. P., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02242-21 · Cited by 71
Severe Candidal Infections in Neutropenic Patients
Swerdloff, J. N., Filler, S. G., & Edwards, J. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_2.s457 · Cited by 70
Different efficacies of common disinfection methods against candida auris and other candida species
Fu, L., Le, T., Liu, Z., Wang, L., Guo, H., Yang, J., Chen, Q., & Hu, J. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.008 · Cited by 70
Influence of recurrent vulvovaginal candidiasis on quality of life issues
Fukazawa, E. I., Witkin, S. S., Robial, R., Vinagre, J. G., Baracat, E. C., & Linhares, I. M. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05228-3 · Cited by 69 · cited 1×
“Even less aggressive forms of invasive candidiasis in the ambulatory setting, such as chronic mucocutaneous disease and recurrent vulvovaginal candidiasis, can have severe cosmetic, psychological, social and functional consequences that greatly impact the QOL of affected patients 148 .”
Hirayama, T., Miyazaki, T., Ito, Y., Wakayama, M., Shibuya, K., Yamashita, K., Takazono, T., Saijo, T., Shimamura, S., Yamamoto, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60792-y · Cited by 69
Neonatal invasive candidiasis: updates on clinical management and prevention
Kilpatrick, R., Scarrow, E. R., Hornik, C., & Greenberg, R. G. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00272-8 · Cited by 69
Mazi, P. B., Olsen, M. A., Stwalley, D., Rauseo, A. M., Ayres, C., Powderly, W. G., & Spec, A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac004 · Cited by 68
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
Bassetti, M., Vena, A., Giacobbe, D. R., Trucchi, C., Ansaldi, F., Antonelli, M. M., Adámková, V., Alicino, C., Almyroudi, M. P., Atchade, E., et al. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00585-6 · Cited by 66
IL-17C is required for lethal inflammation during systemic fungal infection
Huang, J., Meng, S., Hong, S., Lin, X., Jin, W., & Dong, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.56 · Cited by 61
Attributable mortality of candidemia after introduction of echinocandins
Cornely, F. B., Cornely, O. A., Salmanton‐García, J., Koehler, F. C., Koehler, P. A., Seifert, H., Wingen-Heimann, S. M., & Mellinghoff, S. C. (2020) · Mycoses · doi:10.1111/myc.13177 · Cited by 60
Alenazy, H., Alghamdi, A., Pinto, R. L., & Daneman, N. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.092 · Cited by 60
Pfaller, M. A., Carvalhaes, C. G., Smith, C. J., Diekema, D. J., & Castanheira, M. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115016 · Cited by 59
Buetti, N., Tabah, A., Loiodice, A., Ruckly, S., Aslan, A. T., Montrucchio, G. G., Cortegiani, A., Saltoğlu, N., Kayaaslan, B., Aksoy, F., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04166-y · Cited by 59
Biofilm: The invisible culprit in catheter-induced candidemia
Wijaya, M., Halleyantoro, R., & Kalumpiu, J. F. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023025 · Cited by 59
Mamali, V., Siopi, M., Charpantidis, S., Samonis, G., Tsakris, A., Vrioni, G., & on behalf of the Candi-Candi Network (2022) · Journal of Fungi · doi:10.3390/jof8020116 · Cited by 57
Tripathi, A., Liverani, E., Tsygankov, A. Y., & Puri, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013413 · Cited by 56 · cited 1×
“It can conceal cell-wall components to avoid detection by the host immune system in response to metabolic cues, such as low iron and oxygen levels and elevated lactate levels, reducing β-glucan Primer expression 64 .”
Harrison, D. A., Muskett, H., Harvey, S. E., Grieve, R., Shahin, J., Patel, K., Sadique, Z., Allen, E., Dybowski, R., Jit, M., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17030 · Cited by 56
Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia
Martínez‐Jiménez, M. D. C., Muñóz, P., Guinea, J., Valerio, M., Alonso, R., Escribano, P., & Bouza, E. (2014) · Medical Mycology · doi:10.1093/mmy/myt025 · Cited by 56
Race and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Self-citationInvasive Fungal Diseases in Africa: A Critical Literature Review
Bongomin, F., Ekeng, B. E., Kibone, W., Nsenga, L., Olum, R., Itam-Eyo, A. E., Kuate, M. P. N., Pebolo, P. F., Davies, A. A., Manga, M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8121236 · Cited by 52
Defects of the Innate Immune System and Related Immune Deficiencies
Akar-Ghibril, N. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08885-y · Cited by 51
The epidemiology of Candida species in the Middle East and North Africa
Ghazi, S., Rafei, R., Osman, M., El Safadi, D., Mallat, H., Papon, N., Dabboussi, F., Bouchara, J.-P., & Hamze, M. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.006 · Cited by 50
Hoenigl, M., Sprute, R., Arastehfar, A. A., Perfect, J. R., Lass‐Flörl, C., Bellmann, R., Prattes, J., Thompson, G. R., Wiederhold, N. P., Al‐Obaidi, M. M., et al. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2086120 · Cited by 49
Self-citationCeballos-Garzón, A., Peñuela, A., Valderrama, S., Vargas‐Casanova, Y., Ariza, B., & Parra‐Giraldo, C. M. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1136217 · Cited by 49
Chiotos, K., Vendetti, N., Zaoutis, T. E., Baddley, J., Ostrosky-Zeichner, L., Pappas, P., & Fisher, B. T. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw305 · Cited by 48
Self-citationOpportunistic yeast pathogen Candida spp.: Secreted and membrane-bound virulence factors
Lim, S. J., Ali, M. S. M., Sabri, S., Noor, N. D. M., Salleh, A. B., & Oslan, S. N. (2021) · Medical Mycology · doi:10.1093/mmy/myab053 · Cited by 47
Is routine ophthalmoscopy really necessary in candidemic patients?
Vena, A., Muñóz, P., Padilla, B., Valerio, M., Sanchez, M. I., Puig‐Asensio, M., Fortün, J., Fernández‐Ruiz, M., Merino, P., Losa, J. E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183485 · Cited by 45
Cellular metabolism constrains innate immune responses in early human ontogeny
Kan, B., Michalski, C., Fu, H., Au, H. H. T., Lee, K., Marchant, E. A., Cheng, M. F., Anderson‐Baucum, E. K., Aharoni-Simon, M., Tilley, P. A. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07215-9 · Cited by 45
Predictors of outcome in cancer patients with candidemia
Uzun, Ö., & Anaissie, E. J. (2000) · Annals of Oncology · doi:10.1023/a:1008308923252 · Cited by 43
Epidemiology of Culture-confirmed Candidemia Among Hospitalized Children in South Africa, 2012–2017
Shuping, L., Mpembe, R. S., Mhlanga, M., Naicker, S. D., Maphanga, T. G., Tsotetsi, E., Wadula, J., Velaphi, S., Nakwa, F. L., Chibabhai, V., et al. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003151 · Cited by 43
Self-citationVaccines against candidiasis: Status, challenges and emerging opportunity
Sahu, S. R., Bose, S., Singh, M. K., Kumari, P., Dutta, A., Utkalaja, B. G., Patel, S. K., & Acharya, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1002406 · Cited by 43
Cesaro, S., Tridello, G., Blijlevens, N. M. A., Ljungman, P. T., Craddock, C., Michallet, M., Martin, A. M., Snowden, J. A., Mohty, M., Maertens, J. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy150 · Cited by 42
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis
Maseda, E., Martín‐Loeches, I., Zaragoza, R., Pemán, J., Fortün, J., Grau, S., Aguilar, G., Varela, M., Borges-Sa, M., Giménez, M.-J., et al. (2023) · Critical Care · doi:10.1186/s13054-023-04673-6 · Cited by 40
Update on invasive fungal infections in the Middle Eastern and North African region
Osman, M., Al Bikai, A., Rafei, R., Mallat, H., Dabboussi, F., & Hamze, M. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00325-x · Cited by 39
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey
Adam, K.-M., Osthoff, M., Lamoth, F., Conen, A., Erard, V., Boggian, K., Schreiber, P. W., Zimmerli, S., Bochud, P.-Y., Neofytos, D., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab471 · Cited by 37
Candida glabrata is a successful pathogen: An artist manipulating the immune response
Castrejón-Jiménez, N. S., Castillo-Cruz, J., Baltierra‐Uribe, S. L., Hernández-González, J. C., & Estela, G.-P. B. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127038 · Cited by 36
Tam, J. M., Reedy, J. L., Lukason, D. P., Kuna, S. G., Acharya, M., Khan, N. S., Negoro, P. E., Xu, S., Ward, R., Feldman, M. B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801384 · Cited by 35
Filamentation Is Associated with Reduced Pathogenicity of Multiple Non- albicans Candida Species
Banerjee, M., Lazzell, A. L., Romo, J. A., Lopez-Ribot, J. L., & Kadosh, D. (2019) · mSphere · doi:10.1128/msphere.00656-19 · Cited by 35
Candida: Platelet Interaction and Platelet Activity in vitro
Eberl, C., Speth, C., Jacobsen, I. D., Hermann, M., Hagleitner, M., Deshmukh, H., Ammann, C. G., Lass‐Flörl, C., & Rambach, G. (2018) · Journal of Innate Immunity · doi:10.1159/000491030 · Cited by 31
Self-citationHatamoto, M., Aizawa, R., Kobayashi, Y., & Fujimura, M. (2019) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2019.02.013 · Cited by 31
Sharifinejad, N., Zaki‐Dizaji, M., Tebyanian, S., Zainaldain, H., Jamee, M., Rizvi, F. S., Hosseinzadeh, S., Fayyaz, F., Hamedifar, H., Sabzevari, A., et al. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1925543 · Cited by 30
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital
Battistolo, J., Glampedakis, E., Damonti, L., Poissy, J., Grandbastien, B., Kalbermatter, L., Pagani, J., Eggimann, P., Bochud, P., Calandra, T., et al. (2021) · Mycoses · doi:10.1111/myc.13376 · Cited by 29
Candida spp. and phagocytosis: multiple evasion mechanisms
Oliver, J. C., Ferreira, C. B. R. J., Silva, N. C., & Dias, A. L. T. (2019) · Antonie van Leeuwenhoek · doi:10.1007/s10482-019-01271-x · Cited by 28
Chakrabarti, A., Patel, A. K., Soman, R. N., & Todi, S. K. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2257895 · Cited by 27
Daneshnia, F., Polat, S. H., İlkit, M., Fuentes, D., Lombardi, L., Binder, U., Scheler, J., Hagen, F., Mansour, M. K., Butler, G., et al. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad112 · Cited by 26
Self-citationEmerging Diagnostics and Therapeutics for Invasive Fungal Infections
Friedman, D. Z. P., & Schwartz, I. S. (2023) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2023.05.001 · Cited by 26
Lietz, A., Eckel, F., Kiss, H., Noe, M., & Farr, A. (2023) · Mycoses · doi:10.1111/myc.13602 · Cited by 24
Bourassa‐Blanchette, S., Biesheuvel, M. M., Lam, J. C., Kipp, A. J., Church, D. L., Carson, J. A., Dalton, B., Parkins, M. D., Barkema, H. W., & Gregson, D. B. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08050-0 · Cited by 22
Fidel, P. L., Yano, J., Esher, S. K., & Noverr, M. C. (2020) · Journal of Fungi · doi:10.3390/jof6010035 · Cited by 21
The first invasive Candida auris infection in Taiwan
Tsai, Y.-T., Lu, P., Tang, H.-J., Huang, C., Hung, W., Tseng, Y.-T., Lee, K.-M., & Lin, S. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2100280 · Cited by 21
Khanna, N., Stuehler, C., Lünemann, A., Wójtowicz, A., Bochud, P., & LeibundGut‐Landmann, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14350 · Cited by 19
Bretagne, S., Desnos‐Ollivier, M., Sitbon, K., Lortholary, O., Che, D., Dromer, F., & YEASTS, P. O. T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.641965 · Cited by 19
Mechanism underlying renal failure caused by pathogenic Candida albicans infection
JAE-CHEN, S., YOUNG-JOO, J., SEON-MIN, P., KANG SEOK, S., JUNG-HYUN, S., & JUNG-IL, C. (2015) · Biomedical Reports · doi:10.3892/br.2014.393 · Cited by 18 · cited 1×
“The virulence factors of Candida combined with the immune response lead to organ damage and failure 83 .”
First report of Candida auris in Romania: clinical and molecular aspects
Stanciu, A. M., Florea, D., Surleac, M. D., Paraschiv, S., Oţelea, D., Tălăpan, D., & Popescu, G. A. (2023) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-023-01297-x · Cited by 18
Genomic epidemiology of human candidaemia isolates in a tertiary hospital
Chew, K. L., Achik, R., Osman, N. H., Octavia, S., & Teo, J. W. P. (2023) · Microbial Genomics · doi:10.1099/mgen.0.001047 · Cited by 17
Giacobbe, D. R., Asperges, E., Cortegiani, A., Grecchi, C., Rebuffi, C., Zuccaro, V., Scudeller, L., Bassetti, M., & the FUNDICU investigators (2022) · Mycoses · doi:10.1111/myc.13515 · Cited by 16
Loechelt, B. J., Green, M., Gottlieb, P. A., Blumberg, E. A., Weinberg, A., Quinlan, S. C., & Baden, L. R. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu055 · Cited by 15
Bauer, K. A. A., Yu, K. C., Moise, P. A., Finelli, L., Ai, C., Watts, J. A., Ye, G., & Gupta, V. (2023) · Mycoses · doi:10.1111/myc.13573 · Cited by 14
Pang, Y., Ip, M., & You, J. H. S. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2796-4 · Cited by 12
Post Hospital Discharge Functional Recovery of Critical Illness Survivors. Systematic Review
Patsaki, I., Bachou, G., Sidiras, G., Nanas, S., Routsi, C., & Karatzanos, E. (2023) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2023-0011 · Cited by 12
Zakhem, A. E., Mahmoud, O. K., Zakhour, J., Nahhal, S. B., Ghawi, N. E., Omran, N., Sheikh, W. G. E., Tamim, H., & Kanj, S. S. (2023) · Journal of Fungi · doi:10.3390/jof9070769 · Cited by 12
Self-citationChen, D., Wan, X., Kruger, E., Chen, C., Yue, X., Wang, L., & Wu, J. (2018) · Journal of Medical Economics · doi:10.1080/13696998.2017.1417312 · Cited by 10
Infections Simulating Immune Checkpoint Inhibitor Toxicities: Uncommon and Deceptive
Gudiol, C., Hicklen, R., Okhyusen, P. C., Malek, A. E., & Kontoyiannis, D. P. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac570 · Cited by 10
Jin, Y., Wang, Z., Zhu, C., Yang, Q., Lu, Y., Yu, X., Hong, B., Wang, X., & Zhang, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.627166 · Cited by 8
Eichenberger, E. M., Satola, S. W., Neujahr, D. C., Fowler, V. G., Gupta, D. M., Ford, M. L., & Pouch, S. M. (2023) · Clinical Transplantation · doi:10.1111/ctr.15038 · Cited by 8
Candida auris in Intensive Care Setting: The First Case Reported in Portugal
Henriques, J. A. P., Mixão, V., Cabrita, J. M., Duarte, T. I., Sequeira, T., Cardoso, S., Germano, N., Dias, L., Bento, L. F. N., Duarte, S., et al. (2023) · Journal of Fungi · doi:10.3390/jof9080837 · Cited by 8
Gebretekle, G. B., Fentie, A. M., Gebremariam, G. T., Ali, E. E., Erku, D., Alemayehu, T., Abebe, W., & Sander, B. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08662-3 · Cited by 7
Ocular candidiasis in a tertiary hospital in Japan: A 10-year single-center retrospective study
Sano, T., Sasaki, H., Maki, Y., Nagaoka, R., Hamamoto, T., Sugaoka, S., Kanda, T., Takeuchi, M., Kawana, A., & Kimizuka, Y. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.06.019 · Cited by 7
372. Attributable Mortality of Candidemia After Introduction of Echinocandins
Cornely, F. B., Cornely, O. A., Koehler, P. A., Koehler, F. C., & Mellinghoff, S. C. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy210.383 · Cited by 4
Lass‐Flörl, C., Krause, R., Willinger, B., Starzengrüber, P., Decristoforo, P., Neururer, S. B., Kreidl, P., & Aigner, M. (2020) · Journal of Fungi · doi:10.3390/jof6020076 · Cited by 4
Self-citationLi, Y., Fang, D., & Wu, Q. (2023) · PLoS ONE · doi:10.1371/journal.pone.0278800 · Cited by 4
A Candida auris-Specific Adhesin, Scf1, Governs Surface Association, Colonization, and Virulence
Santana, D. J. (2024) · Deep Blue (University of Michigan) · doi:10.7302/22964 · Cited by 4
Prevalence of Ocular Complications in Candidemia: Defining the “Battlefield”
Rauseo, A. M., & Spec, A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad067 · Cited by 3
Cited by
Innate immune response to Candida auris
Holt, A. M., & Nett, J. E. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102510 · Cited by 18
Wu, Y., Zou, Y., Dai, Y., Lu, H., Zhang, W., Chang, W., Wang, Y., Nie, Z., Wang, Y., & Jiang, X. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013220 · Cited by 10
Metadata
- Authors
- Lass-Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky- Zeichner, L., & Govrins, M. A.
- Venue
- Nature Reviews Disease Primers
- Published
- 2024-03-21
- Volume
- 10
- Issue
- 1
- Pages
- 20-20
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4393055189
- Cited by
- 298
- References
- 186
- FWCI
- 35.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.